Wet AMD Trials

Hoffmann-La Roche – LADDER Study – A phase II, multicenter, randomized, active treatment-controlled study of the efficacy and safety of the Ranibizumab Port Delivery System for the sustained delivery of Ranibizumab in patients with Subfoveal Neovascular Age-Related Macular Degeneration. (Actively enrolling)
Allergan – Sequoia Study – Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration. (Actively enrolling)